Table 1 Clinical Characteristics of All Patients with T2DM with and without CHD

Male(%)

40(50)

42(54.5)

0.569

Age(year)

55.51±6.36

59.59±7.10

<0.001

Diabetes duration (year)

6(1,11.75)

12(6,16)

<0.001

HA (%)

37(46)

54(70)

0.003

BMI(kg/m²)

24.47(23.05,27.24)

26.89(24.58,29.38)

<0.001

FPG (mmol/L)

8.50(7.00,10.65)

10(7.55,12.40)

0.039

HbA1C(%)

9.50(7.95,10.80)

8.80(7.30,10.25)

0.065

TyG index

9.52±0.67

9.80±0.77

0.022

TC (mmol/L)

4.76(3.94,5.96)

4.11(3.12,4.95)

<0.001

TG (mmol/L)

2.11(1.37,2.81)

2.46(1.64,3.29)

0.032

HDL-C (mmol/L)

1.02(0.84,1.20)

0.95(0.80,1.16)

0.12

LDL-C (mmol/L)

2.77(1.96,3.49)

2.04(1.54,2.93)

0.001

ALT (U/L)

21.10(15.06,32.28)

24.52(15,35.50)

0.382

AST (U/L)

21.51(15.80,28.69)

24.67(20.27,32.95)

0.076

SCr (umol/L)

57.40(45.90,65.88)

64.50(51.75,79.55)

0.005

BUN (mmol/L)

5.55(4.57,6.51)

5.79(5,7.66)

0.026

Antihypertensive drugs(%)

28(35)

50(64.90)

<0.001

Statins(%)

7(8.70)

46(57.90)

<0.001

Oral hypoglycemic drugs(%)

64(80)

73(94.81)

0.005

Insulin application(%)

48(60)

43(55.84)

0.598